75 related articles for article (PubMed ID: 11205881)
1. Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2.
Damberg M; Ekblom J; Oreland L
Life Sci; 2000 Dec; 68(6):669-78. PubMed ID: 11205881
[TBL] [Abstract][Full Text] [Related]
2. Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain.
Berggård C; Damberg M; Oreland L
Eur Neuropsychopharmacol; 2003 Jan; 13(1):11-7. PubMed ID: 12480117
[TBL] [Abstract][Full Text] [Related]
3. Phenelzine treatment increases transcription factor AP-2 levels in rat brain.
Damberg M; Berggård C; Oreland L
BMC Pharmacol; 2003 Aug; 3():10. PubMed ID: 12943557
[TBL] [Abstract][Full Text] [Related]
4. Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram.
Berggard C; Damberg M; Oreland L
BMC Pharmacol; 2005 Jan; 5():1. PubMed ID: 15663788
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor.
Okamoto H; Shino Y; Hashimoto K; Kumakiri C; Shimizu E; Shirasawa H; Iyo M
Neuropharmacology; 2003 Aug; 45(2):251-9. PubMed ID: 12842131
[TBL] [Abstract][Full Text] [Related]
6. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain.
Ozaki N; Chuang DM
J Neurochem; 1997 Dec; 69(6):2336-44. PubMed ID: 9375664
[TBL] [Abstract][Full Text] [Related]
7. Levels of transcription factors AP-2alpha and AP-2beta in the brainstem are correlated to monoamine turnover in the rat forebrain.
Damberg M; Eller M; Tõnissaar M; Oreland L; Harro J
Neurosci Lett; 2001 Nov; 313(1-2):102-4. PubMed ID: 11684350
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram.
Palotás M; Palotás A; Puskás LG; Kitajka K; Pákáski M; Janka Z; Molnár J; Penke B; Kálmán J
Int J Neuropsychopharmacol; 2004 Dec; 7(4):401-13. PubMed ID: 15315716
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain.
Schildkraut JJ; Roffman M; Orsulak PJ; Schatzberg AF; Kling MA; Reigle TG
Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):193-202. PubMed ID: 981331
[TBL] [Abstract][Full Text] [Related]
10. The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain.
Tamura T; Morinobu S; Okamoto Y; Kagaya A; Yamawaki S
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):375-81. PubMed ID: 11817516
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of AP-2alpha and AP-2beta in the developing chick retina: repression of R-FABP promoter activity by AP-2.
Bisgrove DA; Godbout R
Dev Dyn; 1999 Mar; 214(3):195-206. PubMed ID: 10090146
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.
Boyer PA; Skolnick P; Fossom LH
J Mol Neurosci; 1998 Jun; 10(3):219-33. PubMed ID: 9770644
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
14. Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks.
Rao JS; Rapoport SI; Bosetti F
Neuropsychopharmacology; 2005 Nov; 30(11):2006-13. PubMed ID: 15827566
[TBL] [Abstract][Full Text] [Related]
15. Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.
Seo MK; Lee CH; Cho HY; Lee JG; Lee BJ; Kim JE; Seol W; Kim YH; Park SW
Neuropharmacology; 2014 Apr; 79():222-33. PubMed ID: 24296153
[TBL] [Abstract][Full Text] [Related]
16. Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain.
Wegener G; Bandpey Z; Heiberg IL; Volke V; Trabace L; Rosenberg R; Harvey BH
J Physiol Pharmacol; 2004 Sep; 55(3):575-86. PubMed ID: 15381828
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, expression, and characterization of rat homolog of human AP-2alpha that stimulates neuropeptide Y transcription activity in response to nerve growth factor.
Li BS; Kramer PR; Zhao W; Ma W; Stenger DA; Zhang L
Mol Endocrinol; 2000 Jun; 14(6):837-47. PubMed ID: 10847586
[TBL] [Abstract][Full Text] [Related]
18. Specific modulation of sigma binding sites by the anxiolytic drug opipramol.
Holoubek G; Müller WE
J Neural Transm (Vienna); 2003 Oct; 110(10):1169-79. PubMed ID: 14523629
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic mild stress and imipramine on the proteome of the rat dentate gyrus.
Kedracka-Krok S; Fic E; Jankowska U; Jaciuk M; Gruca P; Papp M; Kusmider M; Solich J; Debski J; Dadlez M; Dziedzicka-Wasylewska M
J Neurochem; 2010 May; 113(4):848-59. PubMed ID: 20180829
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor-BB inhibits rat alpha1D-adrenergic receptor gene expression in vascular smooth muscle cells by inducing AP-2-like protein binding to alpha1D proximal promoter region.
Xin X; Yang N; Faber JE
Mol Pharmacol; 1999 Dec; 56(6):1152-61. PubMed ID: 10570042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
